Please login to the form below
Opinion piece: Patient-centricity and pharma – where are we now?
Patient-centricity is a term that has gained currency in the pharma industry in recent years, and most major companies in the sector are now dedicating resources to ensure that they put the wishes and needs of patients centre-stage in all of their business activities.
But questions
still remain before it is likely to be completely adopted by the pharma
industry, such as how should the industry define what true patient-centricity
is, and how should progress be measured?
Following active monitoring of developments in patient-centricity this year, gauging sentiment in the industry about progress so far, and what work still needs to be done, in a recent webinar, Ashfield Healthcare Communications and pharmaphorum attempted to answer these big questions.
The fundamentals to building a patient-centric business
Earlier this year, Ashfield convened a patient forum of 12 representatives from pharma companies, including large, broad portfolio companies as well as smaller/mid-sized, more specialist providers. It invited contributions from a mix of people with patient-centred roles, from Chief Patient Officer through to regional and functional patient leads.
The participants discussed their companies’ visions for patient-centricity, the strategy and structures they were putting in place, and the key challenges they were encountering. The forum was moderated by patient advocate and former cancer patient Andrew Schorr, co-founder and director of Patient Power, along with Ashfield.
If you would like to understand more about the findings from the patient forum and our recent webinar, click here to read our article in full, or watch our webinar on demand here.
This article was published by Ashfield Healthcare Communications, part of UDG Healthcare plc.
Following active monitoring of developments in patient-centricity this year, gauging sentiment in the industry about progress so far, and what work still needs to be done, in a recent webinar, Ashfield Healthcare Communications and pharmaphorum attempted to answer these big questions.
The fundamentals to building a patient-centric business
Earlier this year, Ashfield convened a patient forum of 12 representatives from pharma companies, including large, broad portfolio companies as well as smaller/mid-sized, more specialist providers. It invited contributions from a mix of people with patient-centred roles, from Chief Patient Officer through to regional and functional patient leads.
The participants discussed their companies’ visions for patient-centricity, the strategy and structures they were putting in place, and the key challenges they were encountering. The forum was moderated by patient advocate and former cancer patient Andrew Schorr, co-founder and director of Patient Power, along with Ashfield.
If you would like to understand more about the findings from the patient forum and our recent webinar, click here to read our article in full, or watch our webinar on demand here.
This article was published by Ashfield Healthcare Communications, part of UDG Healthcare plc.
Company Details
Ashfield
Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK
Latest content on this profile
- Ashfield Healthcare Communications announces two new alliances with Argon Global Healthcare and MIMS
Ashfield
- Caitlin qualifies as ‘Mental Health Champion’
- Project Manager uses personal development funding to support friends' and colleagues' well-being – by Helen Capelin Head of Operational Excellence.
Ashfield
- Ashfield Healthcare Communications is now in Manchester!
- We are happy to announce that we have officially moved into our Manchester office! This will be our 16th office for Ashfield Healthcare Communications along with our others across Europe, America, and Asia-Pacific.
Ashfield
- A reflection of ESMO
- Client Relationship Director Fabienne Wild from Ashfield Meetings & Events reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO).
Ashfield
- Ashfield releases new Divisional Casebook – stories of collaboration, innovation and success
- Today's healthcare companies are looking for an agile and responsive partner to help them overcome complex challenges, deliver innovative products and break into new markets.
Ashfield
- Allegro welcomes third intake of aspiring medical writers to fast-track training programme
- Ashfield Healthcare Communications, a leading global healthcare communications agency, today welcomes its third intake of aspiring medical writers into its accelerated medical writing training programme, Allegro.
Ashfield
